Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 101,578 | 325,892 | 25,833 |
| Marketable Securities | 239,931 | 144,559 | 83,977 |
| Receivables | 668 | 613 | 98 |
| TOTAL | $351,797 | $479,160 | $116,996 |
| Non-Current Assets | |||
| PPE Net | 559 | 582 | 159 |
| Other Non-Current Assets | 1,416 | 1,977 | 43 |
| TOTAL | $1,975 | $2,559 | $202 |
| Total Assets | $353,772 | $481,719 | $117,198 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,726 | 4,041 | 1,990 |
| Accrued Expenses | 10,006 | 5,992 | 4,480 |
| TOTAL | $13,452 | $10,737 | $6,515 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 549 | 1,130 | 2,874 |
| TOTAL | $549 | $1,130 | $2,874 |
| Total Liabilities | $14,001 | $11,867 | $9,389 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 54,420 | 53,641 | N/A |
| Common Shares | 54 | 53 | 3 |
| Retained earnings | -334,223 | -190,780 | -127,974 |
| Other shareholders' equity | 530 | -25 | 230,956 |
| TOTAL | $339,771 | $469,852 | $107,809 |
| Total Liabilities And Equity | $353,772 | $481,719 | $117,198 |